News
Making its debut at SIAVS 2026 in Brazil! 25-Hydroxyvitamin D3 is drawing global attention.
Release time:
2026-08-05
Brazil International Poultry, Livestock and Swine Exhibition
Location: Anhembi Convention Center, São Paulo
From August 4 to 6, the highly anticipated Brazil International Poultry, Livestock and Swine Exhibition (SIAVS 2026) was held with great fanfare at the Anhembi Convention Center in São Paulo. As one of the most influential events in the livestock industry across South America and the world, this year’s SIAVS brought together more than 300 exhibitors from over 60 countries and regions, along with over 30,000 industry professionals, spanning the entire value chain—from poultry and swine to aquaculture and ruminants.

At this premier global event for the livestock industry, Zhejiang Jinlangbo Pharmaceutical Co., Ltd. made a striking appearance with its flagship product—25-hydroxyvitamin D3. In modern intensive farming systems, livestock and poultry commonly face challenges such as inadequate lighting, excessive hepatic metabolic burden, and compromised intestinal health, which significantly reduce the bioavailability of conventional vitamin D3. As the active metabolite of vitamin D3 in the body, 25-hydroxyvitamin D3 bypasses hepatic conversion and is directly absorbed into the bloodstream, thereby more rapidly and effectively elevating circulating levels of active vitamin D. This leads to marked improvements in bone development, eggshell quality, reproductive performance, and immune function, making 25-hydroxyvitamin D3 a key focus of attention across the global animal husbandry sector.

During the exhibition, Jinlangbo stood out as one of the most prominent highlights, thanks to its superior product performance and cutting-edge technological capabilities. Its booth drew numerous livestock farmers, feed manufacturers, and industry experts from Brazil and other Latin American countries, who stopped by to engage in discussions. The company’s team conducted in-depth exchanges with visiting clients, sharing real-world application cases of 25-hydroxyvitamin D3 in the rearing of poultry, swine, and other economically important species. In particular, the compound’s remarkable effects on enhancing egg production and improving reproductive performance in sows were highly praised, earning widespread recognition from customers.

Jinlangbo has consistently focused on the fields of animal nutrition and health, dedicated to providing the global livestock industry with safe, reliable, and high-quality products and nutritional solutions. As the company’s flagship product, 25-hydroxyvitamin D3 is widely incorporated into feed for pigs, poultry, and other species, delivering outstanding performance in promoting skeletal health, boosting immunity, and enhancing production efficiency.

This appearance at Brazil’s SIAVS marks an important step for Jinlangbo in expanding into the Latin American market, strengthening its brand through expert consultations and deepening collaboration through meaningful exchanges. Moving forward, Jinlangbo will remain committed to its business philosophy of “customer-centricity and innovation-driven growth,” delivering high‑quality products and professional services while working hand in hand with partners to advance the efficient and sustainable development of the livestock industry.
More news